Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren’s syndrome (pSS).
Seventy-five pSS patients (mean age 50.03 ± 15.1), 65 (87%) females, and 10 (13%) males. WBC, CRP, RF, ESR, gammaglobulins, C4, C3 component of complement, cryoglobulins, ANA, anti-SS-A, and anti-SS-B antibodies were determined. The disease activity assessed with ESSDAI. Minor salivary gland biopsy (focus score and immunochemistry) was conducted. Results were analyzed with U Mann-Whitney (continuous variables) tests, correlations between quantitative variables assessed with the Spearman correlation coefficient with statistical significance set at p < 0.05. The approval of the Bioethics Committee was obtained.
Two subgroups I-RF(+) (61%) and II-RF(−) (39%) were established, with lower WBC (p = 0.012) and higher ESR (p = 0.016), gammaglobulin concentration (p = 0.007) in group I. Conjunctivitis sicca was more severe in group I. There was positive correlation between RF and lnANA (rho = 0.496), anti-SS-A, anti-SS-B antibodies (rho = 0.448; rho = 0.397 respectively). There was higher disease activity ESSDAI in group I than in group II (Me, 3.0 vs 2.0; p < 0.003). RF correlated negatively with WBC (rho = − 0.374). RF did not correlate with serum concentrations of BAFF, APRIL, CRP, and C3, C4 and with CD19+, CD3+, CD4+, CD 21+, and CD35+.
RF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity.
Mizuochi T, Ito M, Takai K, Yamaguchi K (2009) Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients. Biochem Biophys Res Commun 389(3):512–515. https://doi.org/10.1016/j.bbrc.2009.09.012 CrossRefPubMed
Newkirk MM, Lepage K, Niwa T, Rubin L (1998) Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with Rheumatoid Arthritis (RA). Cell Molec Biol 44:1129–1138
Diaz-Lopez C, Geli C, Corominasetal H (2004) Are there clinical or serological differences between male and female patients with primary Sjögren’s syndrome? J Rheumatol 31(7):1352–1355 PubMed
Shiboski SC, Shiboski CH, Criswell L et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64:475–487 CrossRef
Ramos-Casals M, Font J, Garcia-Carrasco M, , et al. Primary Sjogren syndrome: hematologic patterns of disease expression. (2002) Medicine (Baltimore) 81: 281–292 CrossRef
Nocturne G, Virone A, Ng W-F, le Guern V, Hachulla E, Cornec D, Daien C, Vittecoq O, Bienvenu B, Marcelli C, Wendling D, Amoura Z, Dhote R, Lavigne C, Fior R, Gottenberg JE, Seror R, Mariette X (2016) Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren’s syndrome. Arthritis Rheumatol 68:977–985 CrossRefPubMed
Flores-Chávez A, Kostov B, Solans R et al (2018) Severe, life-threatening phenotype of primary Sjögren’s syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry). Clin Exp Rheumatol 36 Suppl 112(3):121–129 PubMed
Birnbaum J, Lalji A, Saed A, Baer AN (2018) Biopsy-proven small-fiber neuropathy in primary Sjögren’s syndrome: neuropathic pain characteristics, autoantibody findings, and histopathological features. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.23762
Sada PR, Isenberg D, Ciurtin C (2015) Biologic treatment in Sjögren’s syndrome. Rheumatology (Oxford) 54:219–230 CrossRef
- Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients
- Springer London
Journal of the International League of Associations for Rheumatology
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II